PEOPLE - Bausch & Lomb announces the following appointments:
This article was originally published in Clinica
Executive Summary
Following an organisational restructure, Bausch & Lomb (Rochester, New York) has announced the following appointments. Theresa Shappell, previously CEO and co-founder of Excalibur Technologies, has been appointed to the newly created position of vice-president of US commercial operations. Donald Mooney, who has served B&L since 1999, has been appointed vice-president of marketing for the Americas Region. Efrain Rivera, the current president of B&L in Latin America, will assume additional marketing and sales responsibilities in Canada. Further appointments are pending.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.